NCT03163342View on ClinicalTrials.gov

Immune Response Following Seasonal Influenza Vaccination

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 8, 2017

Primary Completion Date

November 21, 2017

Study Completion Date

June 15, 2018

Conditions
Influenza
Interventions
BIOLOGICAL

Licensed seasonal influenza vaccine

20 healthy subjects will be enrolled and receive a single dose of licensed seasonal influenza vaccine

Trial Locations (1)

20850

Optimal Health Research, Rockville

Sponsors

Lead Sponsor

Altimmune, Inc.
All Listed Sponsors
collaborator

Optimal Health Research

OTHER

lead

Altimmune, Inc.

INDUSTRY

NCT03163342 - Immune Response Following Seasonal Influenza Vaccination | Biotech Hunter | Biotech Hunter